$29.20
-0.150 (-0.511%)
At Close: Jun 23, 2026
Immunocore Holdings Plc (IMCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
04:33pm, Wednesday, 10'th Sep 2025
Immunocore Holdings plc (NASDAQ:IMCR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:50 PM EDT Company Participants Travis Coy - CFO, Executive VP & Head of Corporate De
Immunocore to present at upcoming investor conferences
07:00am, Thursday, 04'th Sep 2025
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md.
Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript
09:33am, Saturday, 09'th Aug 2025
Immunocore Holdings plc (NASDAQ:IMCR ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants & - Corporate Participant Bahija Jallal - CEO & Executive Director Clayton Robert
Immunocore (IMCR) Q2 Revenue Jumps 30%
11:54am, Thursday, 07'th Aug 2025
Immunocore Plc (IMCR 0.06%), a biotechnology company specializing in T cell receptor therapies, reported its second quarter 2025 results on August 7, 2025. The main headline was a solid revenue increa
Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics
10:32am, Thursday, 07'th Aug 2025
While the top- and bottom-line numbers for Immunocore (IMCR) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare
Immunocore reports second quarter financial results and provides a business update
07:00am, Thursday, 07'th Aug 2025
KIMMTRAK ® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
02:00am, Thursday, 31'st Jul 2025
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md.
Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
10:56am, Thursday, 24'th Jul 2025
The consensus price target hints at a 72.3% upside potential for Immunocore (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estima
5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment
10:30am, Wednesday, 02'nd Jul 2025
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
08:00am, Monday, 30'th Jun 2025
RIYADH, Saudi Arabia and ISTANBUL and OXFORDSHIRE, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel ther
Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet
11:01am, Monday, 02'nd Jun 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 65.2% in Immunocore (IMCR). While the effectiveness of this highly sought-after metric is questionable, the pos
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
07:00am, Monday, 02'nd Jun 2025
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md.
Is it a Good Idea to Invest in Immunocore Stock Right Now?
10:31am, Friday, 23'rd May 2025
IMCR revenues surge on robust Kimmtrak sales performance. The momentum is likely to continue in 2025.
Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
11:01am, Friday, 16'th May 2025
The mean of analysts' price targets for Immunocore (IMCR) points to an 114.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ana
New Strong Buy Stocks for May 8th
08:36am, Thursday, 08'th May 2025
BTSG, NWFL, MNRO, UBSI and IMCR have been added to the Zacks Rank #1 (Strong Buy) List on May 8, 2025.
Sign In
Buy IMCR